Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Antibody Persistence and Booster Study
NCT00269477Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Feb 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of meningococcal A conjugate vaccine in meningococcal infection (4 arms), sponsored by Sanofi. Primary endpoint: Serum Bactericidal Activity Titer at 28 days. Started Dec 2005; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00269477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269477.